These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21632467)

  • 1. Cancer cells exploit the Eph-ephrin system to promote invasion and metastasis: tales of unwitting partners.
    Wang B
    Sci Signal; 2011 May; 4(175):pe28. PubMed ID: 21632467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of eph receptor kinase activation in cancer cells by coexpressed ephrin ligands.
    Falivelli G; Lisabeth EM; Rubio de la Torre E; Perez-Tenorio G; Tosato G; Salvucci O; Pasquale EB
    PLoS One; 2013; 8(11):e81445. PubMed ID: 24348920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells.
    Astin JW; Batson J; Kadir S; Charlet J; Persad RA; Gillatt D; Oxley JD; Nobes CD
    Nat Cell Biol; 2010 Dec; 12(12):1194-204. PubMed ID: 21076414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential clinical relevance of Eph receptors and ephrin ligands expressed in prostate carcinoma cell lines.
    Fox BP; Tabone CJ; Kandpal RP
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1263-72. PubMed ID: 16516143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem-like Cells from Invasive Breast Carcinoma Cell Line MDA-MB-231 Express a Distinct Set of Eph Receptors and Ephrin Ligands.
    Lucero M; Thind J; Sandoval J; Senaati S; Jimenez B; Kandpal RP
    Cancer Genomics Proteomics; 2020; 17(6):729-738. PubMed ID: 33099474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of contact inhibition of locomotion by Eph-ephrin signalling.
    Batson J; Astin JW; Nobes CD
    J Microsc; 2013 Sep; 251(3):232-41. PubMed ID: 23495724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homotypic receptor-receptor interactions regulating Eph signaling.
    Nikolov DB; Xu K; Himanen JP
    Cell Adh Migr; 2014; 8(4):360-5. PubMed ID: 25530219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Eph receptors and their ligands, ephrins, during lipopolysaccharide fever in rats.
    Ivanov AI; Steiner AA; Scheck AC; Romanovsky AA
    Physiol Genomics; 2005 Apr; 21(2):152-60. PubMed ID: 15671251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Eph/Ephrin family in cancer metastasis: communication at the service of invasion.
    Kandouz M
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):353-73. PubMed ID: 22549394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Eph/ephrin tyrosine kinase in malignant glioma.
    Nakada M; Hayashi Y; Hamada J
    Neuro Oncol; 2011 Nov; 13(11):1163-70. PubMed ID: 21856686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EPH/Ephrin-Targeting Treatment in Breast Cancer: A New Chapter in Breast Cancer Therapy.
    Psilopatis I; Souferi-Chronopoulou E; Vrettou K; Troungos C; Theocharis S
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eph receptors and ephrins in cancer: bidirectional signalling and beyond.
    Pasquale EB
    Nat Rev Cancer; 2010 Mar; 10(3):165-80. PubMed ID: 20179713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of ephrins and Eph receptors in cancer.
    Surawska H; Ma PC; Salgia R
    Cytokine Growth Factor Rev; 2004 Dec; 15(6):419-33. PubMed ID: 15561600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eph receptors and ephrins as targets for cancer therapy.
    Xi HQ; Wu XS; Wei B; Chen L
    J Cell Mol Med; 2012 Dec; 16(12):2894-909. PubMed ID: 22862837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of Eph receptors and ephrins in segmental patterning.
    Xu Q; Mellitzer G; Wilkinson DG
    Philos Trans R Soc Lond B Biol Sci; 2000 Jul; 355(1399):993-1002. PubMed ID: 11128993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A disalicylic acid-furanyl derivative inhibits ephrin binding to a subset of Eph receptors.
    Noberini R; De SK; Zhang Z; Wu B; Raveendra-Panickar D; Chen V; Vazquez J; Qin H; Song J; Cosford ND; Pellecchia M; Pasquale EB
    Chem Biol Drug Des; 2011 Oct; 78(4):667-78. PubMed ID: 21791013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eph-dependent cell-cell adhesion and segregation in development and cancer.
    Nievergall E; Lackmann M; Janes PW
    Cell Mol Life Sci; 2012 Jun; 69(11):1813-42. PubMed ID: 22204021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eph/ephrin signaling in cancer: intricate, puzzling and ... fascinating!
    Alonso-Colmenar LM
    Cell Adh Migr; 2012; 6(2):100-1. PubMed ID: 22814609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eph- and ephrin-dependent mechanisms in tumor and stem cell dynamics.
    Gucciardo E; Sugiyama N; Lehti K
    Cell Mol Life Sci; 2014 Oct; 71(19):3685-710. PubMed ID: 24794629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation.
    Giorgio C; Hassan Mohamed I; Flammini L; Barocelli E; Incerti M; Lodola A; Tognolini M
    PLoS One; 2011 Mar; 6(3):e18128. PubMed ID: 21479221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.